Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: A multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 112, Issue 8, 2005, Pages 1121-1125

  Reid, Peter C ^a   Virtanen Kari, Susanna ^b  

^a BEDFORD HOSPITAL NHS TRUST   (United Kingdom)

^b Bayer Oy   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; MEFENAMIC ACID; CONTRACEPTIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL PAIN; ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; IDIOPATHIC DISEASE; MASTALGIA; MENORRHAGIA; MENSTRUATION; NAUSEA; OVARY CYST; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM; UPPER RESPIRATORY TRACT INFECTION; ADOLESCENT; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL RECORD; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MEDICAL RECORDS; MEFENAMIC ACID; MENORRHAGIA; MENSTRUATION; MIDDLE AGED; TREATMENT OUTCOME;

EID: 24344491969     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2005.00642.x     Document Type: Article

References (27)

1. Coulter A, Bradlow J, Agass M, Martin-Bates C, Tulloch A. Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice. Br J Obstet Gynaecol 1991;98:789-796.
2. Cooper KG, Parkin DE, Garratt AM, Grant AM. Two-year follow up of women randomised to medical treatment or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. Br J Obstet Gynaecol 1999;106:258-265.
3. Kennedy ADM, Sculpher MJ, Coulter A, et al. A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia. Health Technol Assess 2003;7(8):1-45.
4. Warner P, Critchley HOD, Lumsden MA, Campbell-Brown M, Douglas A, Murray G. Referral for menstrual problems: cross sectional survey of symptoms, reasons for referral and management. BMJ 2001;323:24-28.
5. Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol 1984;149:788-793.
6. Higham JM, O'Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990;97:734-739.
7. Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 1997;90:257-263.
8. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998;351:485-489.
9. Fraser IS, McCarron G, Markham R, Resta T. Blood and total fluid content of menstrual discharge. Obstet Gynecol 1985;65:194-198.
10. Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol 2001;98:806-814.
11. Cameron IT, Haining R, Lumsden M-A, Thomas VR, Smith SK. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstet Gynecol 1990;76:85-88.
12. Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996;313:579-582.
13. Milsom I, Andersson K, Andersen B, Rybo G. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991;164:879-883.
14. Irvine GA, Campbell-Brown MB, Lumsden MA, Heikkila A, Walker JJ, Cameron IT. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 1998;105:592-598.
15. Barrington JW, Bowen-Simpkins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol 1997;104:614-616.
16. Kittlesen N, Istre O. A randomised study comparing levonorgestrel intrauterine system (LNG-IUS) and transcervical resection of the endometrium (TCRE) in the treatment of menorrhagia: preliminary results. Gynaecol Endosc 1998;7:61-65.
17. Hurskainen R, Teperi J, Aaalto AM, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 2001;357:273-277.
18. Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia. Randomised trial 5-year follow-up. JAMA 2004;291:1456-1463.
19. Gannon MJ, Day P, Hammadieh N, Johnson N. A new method of measuring menstrual blood loss and its use in screening women before endometrial ablation. Br J Obstet Gynaecol 1996;103:1029-1033.
20. Newton J, Barnard G, Collins W. A rapid method for measuring menstrual blood loss using automatic extraction. Contraception 1977;16:269-282.
21. Fraser IS, McGarron G, Markham R, Robinson M, Smyth E. Long-term treatment of menorrhagia with mefenamic acid. Obstet Gynecol 1983;61:109-112.
22. Scholten PC, Christaens GCML, Haspels AA. Treatment of menorrhagia by intrauterine administration of levonorgestrel. In: Scholten PC, editor. The Levonorgestrel IUD: Clinical Performance and Impact on Menstruation [thesis]. Utrecht, The Netherlands: Utrecht University Hospital, 1989:47-55.
23. Coulter A, Kelland J, Peto V, Rees MCP. Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice. Intl J Tech Assess Health Care 1995;11:456-471.
24. Stewart A, Cummins C, Gold L, Jordan R, Phillips W. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 2001;108:74-86.
25. Cooper KG, Parkin DE, Garratt AM, Grant AM. Two-year follow up of women randomised to medical treatment or Transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. Br J Obstet Gynaecol 1999;106:258-265.
26. Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 1997;68:426-429.
27. Istre O, Trolle B. Levonorgestrel intrauterine system versus endometrial resection. Fertil Steril 2001;76:304-309.